Our communications strategy

The MHRA is responsible for safeguarding public health by making sure that medicines and medical devices work, and are acceptably safe. If it is to be successful in this mission, the Agency must effectively communicate accurate and timely information about the benefits and risks of medicines and medical devices to key stakeholders, including the public, patients, healthcare professionals, researchers and industry.

Communications is therefore mission critical for the Agency. In 2005, the new Communications Division drew together a first communications strategy for the Agency. There have been significant improvements in the Agency’s communications through the implementation of this strategy,  particularly in relation to:

  • media handling, including the creation of an in-house Press Office
  • website development, including the launch of a single unified website
  • understanding stakeholder needs, including commissioning of detailed market research work to help us understand better the perceptions of our stakeholders
  • conferences and events.

Our second Communications Strategy, covering the period until March 2010, briefly reviews the current situation in relation to Agency communications, and the evidence informing future development. It sets out the wider business context for communications activity, before establishing aims, priorities and actions for the three-year period.


Page last modified: 15 June 2007